GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Hemas Holdings PLC (COL:HHL.N0000) » Definitions » 3-Year EPS without NRI Growth Rate

Hemas Holdings (COL:HHL.N0000) 3-Year EPS without NRI Growth Rate : 16.80% (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Hemas Holdings 3-Year EPS without NRI Growth Rate?

Hemas Holdings's EPS without NRI for the three months ended in Dec. 2024 was රු1.01.

During the past 12 months, Hemas Holdings's average EPS without NRI Growth Rate was 26.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 16.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Hemas Holdings was 49.90% per year. The lowest was -28.40% per year. And the median was 13.30% per year.


Competitive Comparison of Hemas Holdings's 3-Year EPS without NRI Growth Rate

For the Conglomerates subindustry, Hemas Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemas Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Hemas Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Hemas Holdings's 3-Year EPS without NRI Growth Rate falls into.


;
;

Hemas Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Hemas Holdings  (COL:HHL.N0000) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Hemas Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Hemas Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemas Holdings Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 75, Braybrooke Place, Hemas House, Colombo, LKA, 02
Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading, and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, and shipping business, among others. It has the following reportable segments: Consumer, Healthcare, Mobility, and other segments. The healthcare segment which generates the majority of the revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals. Geographically, the company generates a majority of its revenue from Sri Lanka.

Hemas Holdings Headlines

No Headlines